Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Sep;30(9):1771.
doi: 10.1681/ASN.2019050505. Epub 2019 Aug 16.

Analysis of Other Confounding Factors Is Mandatory before Considering That Long-Acting Erythropoiesis Stimulating Agents Are Deleterious to Patients on Dialysis

Guy Rostoker  1 , Fanny Lepeytre  2 , Jacques Rottembourg  3
Affiliations
Comment

Analysis of Other Confounding Factors Is Mandatory before Considering That Long-Acting Erythropoiesis Stimulating Agents Are Deleterious to Patients on Dialysis

Guy Rostoker et al. J Am Soc Nephrol. 2019 Sep.
No abstract available

Keywords: anemia; chronic hemodialysis; erythropoietin; hemodialysis hazards; mortality risk.

PubMed Disclaimer

Comment in

  • Authors' Reply.
    Sakaguchi Y, Hamano T, Wada A, Masakane I. Sakaguchi Y, et al. J Am Soc Nephrol. 2019 Sep;30(9):1773-1776. doi: 10.1681/ASN.2019050550. Epub 2019 Aug 16. J Am Soc Nephrol. 2019. PMID: 31420405 Free PMC article. No abstract available.

Comment on

References

    1. Sakaguchi Y, Hamano T, Wada A, Masakane I: Types of erythropoietin-stimulating agents and mortality among patients undergoing hemodialysis. J Am Soc Nephrol 30: 1037–1048, 2019 - PMC - PubMed
    1. Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL: Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: Differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet 388: 294–306, 2016 - PMC - PubMed
    1. Abe M, Hamano T, Wada A, Nakai S, Masakane I: High-performance membrane dialyzers and mortality in hemodialysis patients: A 2-year cohort study from the annual survey of the Japanese Renal Data Registry. Am J Nephrol 46: 82–92, 2017 - PubMed
    1. Mercadal L, Lambert O, Ndoye A, Metzger M, Jacquelinet C, Stengel B: New dialysates and survival. Third congress of the French-speaking Society of Nephrology, Dialysis and Transplantation, Lille, October 1-5, 2018. Available at: https://www.ansm.sante.fr/Declarer-un-effet-indesirable/Materiovigilance.... Accessed May 5, 2019

LinkOut - more resources